Recent treatment advances and practical management of hepatitis D virus.

Hepatitis D virus bulevirtide lonafarnib nucleic acid polymer REP 2139 pegylated interferon

Journal

Clinical medicine (London, England)
ISSN: 1473-4893
Titre abrégé: Clin Med (Lond)
Pays: England
ID NLM: 101092853

Informations de publication

Date de publication:
Jul 2023
Historique:
medline: 14 4 2024
pubmed: 14 4 2024
entrez: 13 4 2024
Statut: ppublish

Résumé

Hepatitis D virus (HDV), also referred to as hepatitis delta virus, is the smallest virus capable of causing human disease. It is unable to replicate on its own and can only propagate in the presence of hepatitis B virus (HBV). Infection with both HBV and HDV frequently results in more severe disease than HBV alone, with higher instances of cirrhosis, liver failure and hepatocellular carcinoma (HCC). Thus, there is a need for effective treatment for HDV; however, currently approved treatment options are very limited both in terms of their efficacy and availability. This makes the management of HDV a challenge for physicians. In this review, we look at the background, diagnosis and treatment of HDV, informed by our hospital data, to set out the optimal management of HDV; we also explore novel treatment options for this disease.

Identifiants

pubmed: 38614656
pii: S1470-2118(24)04589-5
doi: 10.7861/clinmed.2022-0556
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

403-408

Informations de copyright

Copyright © 2023 © 2023 THE AUTHORS. Published by Elsevier Limited on behalf of the Royal College of Physicians. Published by Elsevier Ltd.. All rights reserved.

Auteurs

Kathryn Olsen (K)

Liver Unit, Queen Elizabeth Hospital Birmingham, Birmingham, UK.

Sara Mahgoub (S)

Liver Unit, Queen Elizabeth Hospital Birmingham, Birmingham, UK.

Sarah Al-Shakhshir (S)

Liver Unit, Queen Elizabeth Hospital Birmingham, Birmingham, UK.

Akram Algieder (A)

Liver Unit, Queen Elizabeth Hospital Birmingham, Birmingham, UK.

Sowsan Atabani (S)

Queen Elizabeth Hospital Birmingham, Birmingham, UK.

Ayman Bannaga (A)

Queen Elizabeth Hospital Birmingham, Birmingham, UK. Electronic address: aymanbannaga@yahoo.com.

Ahmed M Elsharkawy (AM)

Queen Elizabeth Hospital Birmingham, Birmingham, UK.

Classifications MeSH